Wealth Enhancement Advisory Services LLC Buys Shares of 4,336 UnitedHealth Group Incorporated (UNH)

Wealth Enhancement Advisory Services LLC bought a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 4,336 shares of the healthcare conglomerate’s stock, valued at approximately $859,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Marshall Wace LLP raised its position in UnitedHealth Group by 441.4% in the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock worth $2,578,000 after purchasing an additional 11,361 shares during the last quarter. American Century Companies Inc. raised its position in UnitedHealth Group by 16.9% in the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock worth $872,051,000 after purchasing an additional 681,111 shares during the last quarter. Schwab Charles Investment Management Inc. raised its position in UnitedHealth Group by 5.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock worth $678,077,000 after purchasing an additional 183,401 shares during the last quarter. Essex Financial Services Inc. raised its position in UnitedHealth Group by 12.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock worth $1,640,000 after purchasing an additional 967 shares during the last quarter. Finally, Factory Mutual Insurance Co. raised its position in UnitedHealth Group by 20.9% in the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock worth $77,245,000 after purchasing an additional 72,000 shares during the last quarter. 86.20% of the stock is currently owned by institutional investors and hedge funds.

In other news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders sold a total of 12,032 shares of company stock valued at $2,658,310 in the last three months. 0.89% of the stock is owned by company insiders.

Several research analysts recently weighed in on the stock. Leerink Swann restated a “buy” rating and issued a $240.00 price objective (up previously from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective for the company in a research report on Thursday, September 21st. Cantor Fitzgerald boosted their price objective on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Wells Fargo & Company restated an “outperform” rating and issued a $245.00 price objective (up previously from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $224.56.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up $0.57 during trading on Friday, hitting $221.82. 6,293,391 shares of the company’s stock traded hands, compared to its average volume of 2,766,697. The company has a market cap of $214,415.88, a PE ratio of 23.05, a price-to-earnings-growth ratio of 1.64 and a beta of 0.66. UnitedHealth Group Incorporated has a 52 week low of $156.09 and a 52 week high of $231.77. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the business earned $2.17 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. research analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date was Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.26%.

ILLEGAL ACTIVITY WARNING: This story was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://www.truebluetribune.com/2017/12/16/wealth-enhancement-advisory-services-llc-buys-shares-of-4336-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply